Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Non-Current Deferred Tax Liability (2016 - 2024)

BioCorRx's Non-Current Deferred Tax Liability history spans 11 years, with the latest figure at $39349.0 for Q4 2024.

  • For Q4 2024, Non-Current Deferred Tax Liability fell 80.32% year-over-year to $39349.0; the TTM value through Dec 2024 reached $39349.0, down 80.32%, while the annual FY2024 figure was $39349.0, 80.32% down from the prior year.
  • Non-Current Deferred Tax Liability for Q4 2024 was $39349.0 at BioCorRx, down from $199952.0 in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $573541.0 in Q4 2020 and bottomed at $39349.0 in Q4 2024.
  • The 5-year median for Non-Current Deferred Tax Liability is $361781.0 (2022), against an average of $322912.2.
  • The largest annual shift saw Non-Current Deferred Tax Liability skyrocketed 176.37% in 2020 before it crashed 80.32% in 2024.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $573541.0 in 2020, then dropped by 23.29% to $439938.0 in 2021, then decreased by 17.77% to $361781.0 in 2022, then plummeted by 44.73% to $199952.0 in 2023, then plummeted by 80.32% to $39349.0 in 2024.
  • Per Business Quant, the three most recent readings for BICX's Non-Current Deferred Tax Liability are $39349.0 (Q4 2024), $199952.0 (Q4 2023), and $361781.0 (Q4 2022).